You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ADRX Conversion Disclosure
Chimovits Erez · SEC Form 4 · Filed Sep 30, 2026
Conversion
Calculated transaction value
$0
Chimovits Erez Director
ADRX
Transaction date
Sep 28, 2026
Public filing date
Sep 30, 2026
Filing lag
Filed 2 days later
ADRX daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Series C Preferred Stock on Common Stock
- Quantity / price
- 256,448 shares @ $0
- SEC ownership
- Indirect
- Transaction code
- C
- Form
- 4
- Filing identifier
- 0000947871-26-000912
Filing cohort
Transactions in this filing
Showing 9 of 9
Trades
9
Issuers
1
Estimated value
$1.05M
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Adarx Pharmaceuticals, Inc. ADRX | Conversion | Sep 28, 2026 | $0 |
| Adarx Pharmaceuticals, Inc. ADRX | Conversion | Sep 28, 2026 | Not reported |
| Adarx Pharmaceuticals, Inc. ADRX | Conversion | Sep 28, 2026 | Not reported |
| Adarx Pharmaceuticals, Inc. ADRX | Conversion | Sep 28, 2026 | Not reported |
| Adarx Pharmaceuticals, Inc. ADRX | Buy | Sep 28, 2026 | $1.05M |
| Adarx Pharmaceuticals, Inc. ADRX Current | Conversion | Sep 28, 2026 | $0 |
| Adarx Pharmaceuticals, Inc. ADRX | Conversion | Sep 28, 2026 | $0 |
| Adarx Pharmaceuticals, Inc. ADRX | Conversion | Sep 28, 2026 | Not reported |
| Adarx Pharmaceuticals, Inc. ADRX | Conversion | Sep 28, 2026 | $0 |